期刊文献+

脑钠肽、和肽素检测对冠脉病变程度的预测价值研究 被引量:5

Predictive value of brain natriuretic peptide and copeptin levels in detecting coronary artery disease
原文传递
导出
摘要 目的:探讨冠心病患者脑钠肽、和肽素与冠脉病变程度之间的关系。方法:入选急性心肌梗死患者(AMI组)40例、不稳定型心绞痛患者(UAP)36例、稳定型心绞痛患者(SAP组)51例和健康对照者30例,比较各组患者脑钠肽、和肽素水平与冠脉病变支数、冠脉Gensini评分相关性。结果:AMI组、UAP组脑钠肽、和肽素水平显著高于SAP组和对照组,且AMI组明显高于UAP组,差异均有统计学意义(P<0.05)。脑钠肽、和肽素水平与冠脉病变支数、左主干病变程度、冠脉Gensini评分呈正相关(P<0.05)。结论:脑钠肽、和肽素水平可反映冠心病患者临床症状与冠脉病变的严重程度。 Objective: To study the relationship between brain natriuretic peptide (BNP), copeptin levels and the degree of coronary artery disease (CAD) in patients with CAD. Method: 40 patients with acute myocardial infarction (AMI), 36 patients with unstable angina pectoris (UAP), 51 patients with stable angina pectoris (SAP) and 30 cases of healthy controls were selected. The correlations of the number of impaired coronary arteries (CA), left main coronary stenosis and Gensini scores of CA with levels of BNP and Copeptin were compared. Results: BNP and copeptin levels of AMI, UAP group were significantly higher than that of SAP and control group. BNP and copeptin levels of AMI were significantly higher than that of UAP group, the differences were statistically significant (P 〈0.05). BNP, copeptin levels and coronary lesion vessels, left main coronary stenosis, coronary Gensini score were positively correlated (P 〈0.05). Conclusion: BNP and copeptin levels reflect the severity of clinical symptoms and impaired coronary arteries of CAD patients.
出处 《现代生物医学进展》 CAS 2010年第19期3711-3713,共3页 Progress in Modern Biomedicine
关键词 冠心病 脑钠肽 和肽素 心绞痛 心肌梗死 coronary heart disease; brain natriuretic peptide; copeptin; angina; myocardial infarction;
  • 相关文献

参考文献11

  • 1Morgenthaler NG, Struck J,Alonso C et al. Assay for the measurement of copeptin,a stable peptide derived from the precursor of vasopressin [J]. Clin Chem, 2006,52:112-119.
  • 2Palazzuoli A, Deckers J, Calabro A, et al. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non - ST - elevation coronary syndromes and preserved systolic function [J]. Am J Cardiol, 2006, 28 (10): 1322-1328.
  • 3Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983,51 (3): 606-611.
  • 4Yeo CJ,Camerom JL, Sohn TA, et al. Six hundred fifty consecutive pancreatic oduodenectomies in the 1990s [J]. Ann Surg, 1997,26(6):248-260.
  • 5Tousoulis D, Kampoli AM, Stefanadi E, etal. New biochemical markers in acute coronary syndromes [J]. Curt Med Chem,2008,15(13): 1288-1296.
  • 6Alina Mihaela Pascu, Mariana R&abreve.Plasma brain natriuretic peptide (BNP) levels predict acute right ventricular dysfunction in pulmonary embolism - prospective study on 70 patients [J].Endocrine Abstracts,2007,14(10):63.
  • 7Dunser MW.Wenzel V.Mayr AJ. Management of vasodilatory shock: defining the role of arginine vasopressin[J],Drugs,2003,63(3):237-56.
  • 8Bhandari SS, Loke I, Gender and renal function influence plasma levels of eopeptin in healthy individuals [J]. Clin Sci (Lond), 2009 Feb, 116(3):257-63.
  • 9Stoiser B, Mortl D, Halsmann M, et al. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure [J]. Eur J Clin Invest, 2006,36: 771-778.
  • 10Tang WH,Francis GS,Morrow DA,et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure [J]. Circula- tion, 2008,41 : 210-222.

同被引文献26

  • 1Morgenthaler NG;Struck J;Bergm ann A.Assay for the measurement of copeptin,a stable peptide derived from the precursor of vasopressin,2006(01).
  • 2Wayne L. Miller,Karen A. Hartman,David O. Hodge,Stacy Hartman,Joachim Struck,Nils G. Morgenthaler,Andreas Bergmann,Allan S. Jaffe.Response of Novel Biomarkers to BNP Infusion in Patients with Decompensated Heart Failure: A Multimarker Paradigm[J]Journal of Cardiovascular Translational Research,2009(4).
  • 3Alfons Gegenhuber,Joachim Struck,Benjamin Dieplinger,Werner Poelz,Richard Pacher,Nils G. Morgenthaler,Andreas Bergmann,Meinhard Haltmayer,Thomas Mueller.Comparative Evaluation of B-Type Natriuretic Peptide, Mid-Regional Pro-A-type Natriuretic Peptide, Mid-Regional Pro-Adrenomedullin, and Copeptin to Predict 1-Year Mortality in Patients With Acute Destabilized Heart Failure[J]Journal of Cardiac Failure,2007(1).
  • 4Voors AA,von Haehling S,Anker SD,et al.C-terminal provasopressin (copeptin)is a strong prognostic marker in patients with heart failure after an acute myocardial infarction:results from the OPTIMAAL studyEuropean Heart Journal,2009.
  • 5Tentzeris I,Jari R,Farhan S,et al.Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic hearts failureThe Journal of Clinical Endocrinology,2011.
  • 6Alehagen U,Dahlstrom U,Rehfeld J F,et al.Association of copeptin and N-terminal proBNP concentrations with risk of cardiocvascular death in older patients with symptoms of heart failureThe Journal of The American Medical Association,2011.
  • 7Dieplinger B,Gegenhuber A,Haltmayer M,et al.Evaluation of novel biomarkers for the diagnosis of acute destabilized heart failure in patients with shortness of breathHeart,2009.
  • 8凤英,曹中朝.心房颤动与血浆脑钠肽关系的研究进展[J].中国医药,2008,3(8):511-512. 被引量:4
  • 9叶忠,郑兴.冠心病患者血浆和肽素水平的测定及其对冠脉病变程度的诊断价值[J].第二军医大学学报,2009,30(10):1154-1157. 被引量:5
  • 10来月红,毛威.脑钠尿肽在冠心病临床应用的研究进展[J].心脏杂志,2010,22(3):450-452. 被引量:1

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部